Francisco José Blasco Abril — investor profile photo

Francisco José Blasco Abril

CEO @ Sperm Analysis Technologies | Biotech, AI, Sperm Analysis

📍 Greater Valencia Metropolitan Area, Spain🔄 Updated November 2026💼 3 investments📅 7 years investing🗓 Last invested May 2020
Operator-angel🌍 Spain
3
Total investments
1
Early stage
0
Mid stage
0
Late stage
7y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
CEO, Shareholder
May 2020
Sperm Analysis Technologies is a company focused on the development, manufacture and commercialisation of CASA systems and products in general for sperm analysis and research.
early stageBiotechnology
Experience · 11 entries
All (11)
Investments (3)
Founder (7)
2020
Co-Founder. Legal responsible at Spain
Sep 2020
Cercle is an AI technology company with the mission to advance healthcare for all women. Cercles platform, the Cercle™ Biomedical Graph, uses AI to analyze billions of anonymized data points securely drawn from hospitals, clinics and research labs from all over the globe. The Graph turns raw, unstructured and disconnected womens healthcare data points into clear insights for doctors, hospitals, research centers, pharmaceutical companies, labs and clinics so they can run more efficient businesses and provide more personalized care. Healthcare is inundated with data -- but extracting insights from that data is expensive and time consuming. Cercles AI platform addresses this challenge for companies across the womens healthcare, including providers, payors and pharma. We offer a full suite of cutting-edge products, all powered by Cercles Biomedical Graph, including: 1) Prediction tools -- Tools business and clinical teams can use to inform personalized treatments and plans for each patient. 2) Data access tools -- Data teams and lab directors can query and visualize structured biomedical data to accelerate health innovation. 3) Modeling and insights products -- Advanced modeling tools help healthcare providers with financial and operational strategies. 4) Coming soon: AI Agents for real-time insights -- We are connecting LLMs to real world data (billions of womens healthcare data points) so that you can interrogate your data in real-time and extract high-quality insights with no AI hallucinations. To read more about Cercles suite of products and to schedule a demo, visit www.cercle.ai
OvumIA
Co-founder
Jul 2020
CEO, Shareholder
May 2020
Sperm Analysis Technologies is a company focused on the development, manufacture and commercialisation of CASA systems and products in general for sperm analysis and research.
early stageBiotechnology
2019
Partner
Jul 2019
BIGBAN, fundada en 2007 como entidad de carácter privado e independiente, se posiciona como un referente del sector de inversión privada en capital semilla y early stage. La asociación aglutina a más de 130 business angels de distinta tipología y ha canalizado más de 20 millones de inversión privada en proyectos empresariales innovadores. Formamos a los dos colectivos para tener un sector robusto y profesionalizado, dinamizando un nuevo tejido empresarial. Miembro de AEBAN - Asociación Nacional de Business Angels. Miembro de EBAN - European Business Angels Network.
Sports Around You, SL
Shareholder
Mar 2019
Show all 11 entries ↓
Investment activity
2019–2020 · 3 investments
2019220201
Recent (last 2 years)Earlier
Investor lists
Lists that match Francisco José's portfolio